Last week, J&J JNJ announced plans to invest more than $55 billion over the next four years to expand its manufacturing footprint in the United States as the Trump administration considers ...
Zacks Investment Research on MSN4d
Here's How to Play JNJ Stock as it Announces $55B US Investment PlanJ&J JNJ announced plans to invest more than $55 billion over the next four years to expand its manufacturing footprint in the ...
The label expansion could help J&J establish Tremfya as a successor to Stelara, which is now facing a growing biosimilar ...
The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous ...
JERSEY CITY, N.J., March 27, 2025 /PRNewswire/ -- Celltrion, Inc., today announced that STEQEYMA ® (ustekinumab-stba), a biosimilar to STELARA ® (ustekinumab) has been added to the Costco Member ...
The F8 formulation is 8 times more concentrated than Egrifta and 2 times more concentrated than the current F4 formulation, Egrifta SV.
Studio Ghibli's distinctive style can now be applied to any image using OpenAI's new "Images in ChatGPT" feature. This tool has captivated fans, transforming ordinary images into Ghibli's serene ...
Total Revenues in 2024 reached $492 million, representing a 427% increase over prior year Product Revenues in 2024 reached $273 million, representing a 462% increase over prior year Adjusted ...
As Congress gears up to pass President Trump’s massive legislative package, one of the biggest fights is over the future of Medicaid. To make their targeted budget numbers, Republicans will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback